| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1008677370 |
| P356 | DOI | 10.1186/1471-2407-10-132 |
| P932 | PMC publication ID | 2856551 |
| P698 | PubMed publication ID | 20377868 |
| P5875 | ResearchGate publication ID | 43079224 |
| P50 | author | Helge Taubert | Q56519855 |
| Harun M Said | Q84024787 | ||
| P2093 | author name string | Dirk Vordermark | |
| Matthias Bache | |||
| Matthias Kappler | |||
| Peter Würl | |||
| Swetlana Rot | |||
| Thomas Greither | |||
| Matthias Kotzsch | |||
| Henri Wichmann | |||
| Antje Hahnel | |||
| P2860 | cites work | Osteopontin influences the invasiveness of pancreatic cancer cells and is increased in neoplastic and inflammatory conditions. | Q54657752 |
| Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: Prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1α-related markers, and hemoglobin levels | Q56565978 | ||
| Low detection rate of p53 antibodies in sera of soft tissue sarcoma patients | Q56566039 | ||
| Osteopontin expression in a group of lymph node negative breast cancer patients | Q62497180 | ||
| Grading of soft tissue sarcomas: experience of the EORTC Soft Tissue and Bone Sarcoma Group | Q72748728 | ||
| Osteopontin expression in primary sarcomas of the pulmonary artery | Q77412582 | ||
| Expression of osteopontin and vascular endothelial growth factor in benign and malignant bone tumors | Q78439155 | ||
| Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients | Q80328189 | ||
| Stem cell-associated genes are extremely poor prognostic factors for soft-tissue sarcoma patients | Q80382767 | ||
| Clinical significance of osteopontin expression in cervical cancer | Q80526631 | ||
| Clinical significance of osteopontin expression in T1 and T2 tongue cancers | Q80568672 | ||
| Prognostic significance of osteopontin expression in human gastric carcinoma | Q81353718 | ||
| Expression of osteopontin and HGF/met in adult soft tissue tumors | Q81419450 | ||
| Clinical implications of osteopontin in metastatic lesions of uterine cervical cancers | Q83288232 | ||
| Effects of THBS3, SPARC and SPP1 expression on biological behavior and survival in patients with osteosarcoma | Q21260421 | ||
| Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration | Q28145089 | ||
| Osteopontin-c is a selective marker of breast cancer | Q28254727 | ||
| Osteopontin localizes to the nucleus of 293 cells and associates with polo-like kinase-1 | Q28265709 | ||
| An osteopontin splice variant induces anchorage independence in human breast cancer cells | Q28281854 | ||
| Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival. | Q30320605 | ||
| Plasma osteopontin levels in patients with head and neck cancer and cervix cancer are critically dependent on the choice of ELISA system | Q33254071 | ||
| The functional and clinical roles of osteopontin in cancer and metastasis. | Q34119050 | ||
| P700: the primary electron donor of photosystem I. | Q34424983 | ||
| The metastasis gene osteopontin: a candidate target for cancer therapy | Q34515780 | ||
| Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancer. | Q36615218 | ||
| Osteopontin: an emerging therapeutic target for anticancer therapy | Q36675504 | ||
| Osteopontin: regulation in tumor metastasis | Q37020157 | ||
| Detection and specific targeting of hypoxic regions within solid tumors: current preclinical and clinical strategies | Q37090020 | ||
| Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects | Q39931959 | ||
| Osteopontin expression profiles predict pathological and clinical outcome in breast cancer. | Q40005261 | ||
| The inhibition of in vivo tumorigenesis of osteosarcoma (OS)-732 cells by antisense human osteopontin RNA. | Q40064120 | ||
| Prognostic significance of osteopontin expression in human prostate cancer | Q40343105 | ||
| Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness. | Q40349236 | ||
| Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer. | Q44030350 | ||
| Co-expression of survivin and TERT and risk of tumour-related death in patients with soft-tissue sarcoma | Q44321401 | ||
| Osteopontin but not osteonectin messenger RNA expression is a prognostic marker in curatively resected non-small cell lung cancer | Q44795382 | ||
| Expression of osteopontin in human glioma. Its correlation with the malignancy | Q48076092 | ||
| An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma. | Q53334223 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypoxia | Q105688 |
| P304 | page(s) | 132 | |
| P577 | publication date | 2010-04-08 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | Elevated tumor and serum levels of the hypoxia-associated protein osteopontin are associated with prognosis for soft tissue sarcoma patients | |
| P478 | volume | 10 |
| Q30317585 | A pilot study on potential plasma hypoxia markers in the radiotherapy of non-small cell lung cancer. Osteopontin, carbonic anhydrase IX and vascular endothelial growth factor |
| Q35719602 | Clinical significance of serum biomarkers in pediatric solid mediastinal and abdominal tumors |
| Q34173692 | Effects of osteopontin inhibition on radiosensitivity of MDA-MB-231 breast cancer cells |
| Q101237465 | Hypoxia and its therapeutic possibilities in paediatric cancers |
| Q36271573 | Identification of therapeutic targets for glioblastoma by network analysis |
| Q37378867 | Inflammatory stress and sarcomagenesis: a vicious interplay |
| Q38682324 | Molecular Predictors of Radiotherapy Response in Sarcoma |
| Q37896087 | Osteopontin: a potentially important therapeutic target in cancer |
| Q39192350 | Osteopontin: its potential role in cancer of children and young adults |
| Q34939938 | Pre- and post-translational regulation of osteopontin in cancer |
| Q35797850 | Preoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma |
| Q64247790 | Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients |
| Q30318127 | Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients |
| Q27025579 | The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunities |
| Q38211082 | The role of inflammation in sarcoma |
| Q47733296 | Tumor expression of survivin, p53, cyclin D1, osteopontin and fibronectin in predicting the response to neo-adjuvant chemotherapy in children with advanced malignant peripheral nerve sheath tumor. |
Search more.